Ropivacaine versus bupivacaine for spinal anaesthesia in patients undergoing unilateral lower limb surgery

Study identifier:D0695L00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomised, double-blind, multi-centre, parallel group study comparing efficacy and safety of 5 mg/ml ropivacaine and 5 mg/ml bupivacaine for spinal anaesthesia in patients undergoing unilateral lower limb surgery

Medical condition

Anesthesia,Spinal

Phase

Phase 3

Healthy volunteers

No

Study drug

Ropivacaine, Bupivacaine

Sex

All

Actual Enrollment

220

Study type

Interventional

Age

18 Years - 70 Years

Date

Study Start Date: 01 Apr 2006
Primary Completion Date: -
Study Completion Date: 01 Sept 2006

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria